Afjal Miah

Investigator, Medicinal Chemistry, Protein Degradation
Nina E. Weisser
I joined GlaxoSmithKline in 2016, where I have worked on various hit-to-lead and lead optimisation projects including PDE4, MetAP2 and CCR4. Whilst working at GSK, I have completed an Industrial PhD in collaboration with the University of Strathclyde, under the direction of Professor Jonathan Percy and Dr Pan Procopiou. I am a founder member of GSKs Protein Degradation group established in 2013, where I am currently working, and have led chemistry programs in discovery and lead optimisation of PROTACs and E3 ligase projects. My research interests include: new modalities in protein degradation, E3 Ligases, the ubiquitin proteasome system and Bromodomain proteins.


No data was found